Allogene Therapeutics, Inc. (ALLO)

NASDAQ: ALLO · Real-Time Price · USD

2.530

-0.120 (-4.53%)

At close: Mar 3, 2026, 4:00 PM EST

2.530

0.00 (0.00%)

Pre-market: Mar 4, 2026, 5:45 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Pharmaceuticals	22.00K	95.00K	156.00K	114.09M	-
Pharmaceuticals Growth	-76.84%	-39.10%	-99.86%	-	-
Total	22.00K	95.00K	156.00K	114.09M	-
Total Growth	-76.84%	-39.10%	-99.86%	-	-

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
United States	22.00K	95.00K	156.00K	114.09M	-
United States Growth	-76.84%	-39.10%	-99.86%	-	-
Total	22.00K	95.00K	156.00K	114.09M	-
Total Growth	-76.84%	-39.10%	-99.86%	-	-

Source: S&P Global Market Intelligence.